Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
235.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (2.083%)
Market Cap: £84.50m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Directorate change

15 Jan 2026 07:00

RNS Number : 9549O
Alumasc Group PLC (The)
15 January 2026
 

 15 January 2026

 

 

The Alumasc Group plc

 

("Alumasc" or "Group")

Directorate change

CEO Appointment

Alumasc Group plc, the sustainable building products, systems and solutions group, is pleased to announce the appointment of Pamela Bingham as Chief Executive Officer ("CEO").

Pamela has over 20 years' experience at international manufacturing businesses, most recently as CEO of Eriks UK & Ireland, a €370m revenue industrial services business, where she was responsible for leading its commercial and operational growth strategy from 2023 until its successful sale by Lone Star Funds in 2025. Before Eriks, Pamela was CEO of Glen Dimplex Heating and Ventilation, the largest division of the Glen Dimplex Group, with revenues of €500m. Prior to that Pamela held Managing Director positions at CRH plc, The Weir Group PLC and Rotork plc. Pamela also served as a Non-executive director of Tyman plc from 2018 until 2024. Pamela holds a Law degree from the University of Edinburgh and an MBA from Warwick Business School.

Pamela will join Alumasc's Board on 2 March 2026 as CEO Designate and will take over as CEO on the retirement of the current Group Chief Executive, Paul Hooper, on 31 March 2026. The Board thanks Paul for his 25 years' service and commitment to Alumasc, and his leadership over a period of transformation and growth for the Group.

Vijay Thakrar, Chair of Alumasc, said:

"I am delighted to announce the appointment of Pamela as the new CEO of the Group. She brings extensive commercial experience as well as a record of value creation through organic and inorganic growth, employee engagement, digital transformation and customer loyalty, all of which will be helpful in leading Alumasc during its next stage of growth.

After 25 years with the business, we will be sad to see Paul Hooper leave us and are grateful for the significant contribution he made over that time. He leaves a strong and agile Group, well positioned to capitalise on the opportunities in its markets."

Pamela Bingham, CEO designate, said:

"I am delighted to be joining Alumasc at such an exciting time in its journey. It is a unique company that positively contributes to the decarbonisation of the building and construction sector with its sustainable building products and innovative products and solutions. I look forward to working with Vijay, the Board, Alumasc's management team and our people to build upon Alumasc's successful growth in recent years."

Further information regarding Pamela Bingham, in accordance with Schedule 2 paragraph (g) of the AIM Rules for Companies is set out below:

Pamela Ann Bingham (aged 56) has held the following directorships and/or partnerships within the past 5 years:

Previous directorships (within the last 5 years)

Brymill Limited

ERIKS Industrial Services Limited

ERIKS Industrial Services (Ireland) Limited

ERIKS Transportation GmbH

ERIKS UK Holdings Limited

Farrans Ltd

Flexible Hose Supplies (Northampton) Limited

Filoform UK Ltd

NAL Ltd

NAL Developments Ltd

Northstone (NI) Limited

Quanex Extruded Solutions Ltd (formerly Tyman plc)

Resilient Living Ltd

Resilient Property Ltd

Rotork UK Limited

Smarter Data Management Limited

Weir Minerals Europe Limited

Wyko Group Ltd

As at the date of this announcement, Pamela Bingham is not beneficially interested in any Ordinary Shares in the Company.

 

Enquiries:

The Alumasc Group plc

Vijay Thakrar (Chair)

Paul Hooper (Chief Executive)

Simon Dray (Group Finance Director)

Helen Ashton (Group Company Secretary)

 

+44 (0)1536 383844

 

Cavendish Capital Markets (Nominated Adviser & Joint Broker)

Julian Blunt, Edward Whiley (Corporate Finance)

Tim Redfern (ECM)

 

 

+44 (0)207 220 0500

Peel Hunt (Joint Broker)

Mike Bell

Ed Allsopp

 

+44 (0)207 418 8831

Camarco (Financial PR)

Ginny Pulbrook 

Tilly Butcher

 

alumasc@camarco.co.uk

+44 (0)203 757 4992

LEI: 2138002MV11VKZFJ4359

Notes to Editors:

Alumasc is a UK-based supplier of premium sustainable building products, systems and solutions. Around 80% of Group sales are driven by building regulations and specifications (architects and structural engineers) because of the performance characteristics offered.

The Group has three business segments with strong positions and brands in their individual markets. The three segments are: Water Management; Building Envelope; and Housebuilding Products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAVZLFFQFLFBBB
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.